# Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus

Study · id `cardio:ct-nct04847219` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04847219](<https://clinicaltrials.gov/study/NCT04847219>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04847219

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 239 participants.

## Technical summary

Registry record NCT04847219. Randomized; double masking; primary purpose treatment. Start 2019-10-09 (actual); primary completion 2021-04-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 239 participants (enrolled count; ClinicalTrials.gov record NCT04847219, source copy `cardio:ctgov-nct04847219-2021-09-27`, retrieved 2026-10-26)
- Started: 2019-10-09 (actual) (ClinicalTrials.gov record NCT04847219, source copy `cardio:ctgov-nct04847219-2021-09-27`, retrieved 2026-10-26)
- Primary completion: 2021-04-30 (actual) (ClinicalTrials.gov record NCT04847219, source copy `cardio:ctgov-nct04847219-2021-09-27`, retrieved 2026-10-26)
- Completion: 2021-04-30 (actual) (ClinicalTrials.gov record NCT04847219, source copy `cardio:ctgov-nct04847219-2021-09-27`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04847219, source copy `cardio:ctgov-nct04847219-2021-09-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04847219-2021-09-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus
- Condition: Type 2 Diabetes
- Intervention (Device): Professional flash glucose mornitoring
- Intervention (Device): Personal flash glucose mornitoring
- Lead sponsor: Nanjing First Hospital, Nanjing Medical University
- Lead sponsor class: OTHER
- Collaborator: Wuxi Hospital of Traditional Chinese Medicine
- Collaborator class: UNKNOWN
- Collaborator: Wuxi People's Hospital Affiliated to Nanjing Medical University
- Collaborator class: UNKNOWN
- Collaborator: Huai'an Second People's Hospital and the Affiliated Huai'an Hospital of Xuzhou Medical University
- Collaborator class: UNKNOWN
- Collaborator: The Affiliated Suqian First People's Hospital of Nanjing Medical University
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Nanjing First Hospital, Nanjing Medical University (`cardio:org-nanjing-first-hospital-nanjing-medical-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy (`cardio:pubmed-40620795`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 2123f9d48f21b6ea7299f4162946ce30878bc373be1c7235529d0dfe229e3cee
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
